全球 microRNA 逆转录市场 - 行业趋势和 2029 年预测

全球 microRNA 逆转录市场分析与洞察

MicroRNA 是转录后调节基因表达的小型内源性 RNA。MicroRNA 大量存在于哺乳动物中，靶向人类和其他哺乳动物约 60% 的基因。MicroRNA 逆转录是基因表达的关键调节剂，也是生物标志物开发的有希望的候选者。

单个 microRNA 可以靶向数百个 mRNA 并影响许多基因的表达。此外，microRNA 逆转录涉及许多过敏性疾病，包括嗜酸性食管炎、哮喘等，这预计将增加对 microRNA 逆转录的需求。目前用于 microRNA 逆转录的方法，如 RNA 测序、微阵列和定量 PCR，预计将推动市场增长。

癌症、神经系统疾病等疾病的发病率不断上升，预计将推动 microRNA 逆转录市场的发展。此外，由于基因组学技术和计算方法的进一步发展，microRNA 逆转录市场预计将呈指数级增长。此外，使用这些分子在临床前研究中进行的治疗演示预计将在未来几年增加研发投资。

此外，还有各种试剂盒可供选择，例如 TaqMan microRNA 逆转录酶，专门用于生成特定 cDNA，与 TaqMan microRNA 检测一起使用也有望促进 microRNA 逆转录酶市场的增长。microRNA 逆转录需求的增加鼓励了主要市场参与者实施更新的技术和策略，通过产品发布、收购、策略和协议来改进各自类别的设备。

全球 microRNA 逆转录市场具有支持性，旨在减缓癌症和神经系统疾病的进展。Data Bridge 市场研究分析，全球 microRNA 逆转录市场在 2022 年至 2029 年的预测期内将以 16.4% 的复合年增长率增长。

Global microRNA Reverse Transcription Market

Drivers

• Increasing Prevalence of Cancer and Neurological Disorder

MicroRNA reverse transcription is used for biomarkers in cancer through mediated intercellular communication in neurology for the diagnosis and prognosis of alzheimer’s disease. MicroRNA reverse transcription could also be used in other fields like cardiology, as a faster and more accurate means of diagnosis for acute cardiovascular disease or heart failure and in the case of infectious diseases for the diagnosis of sepsis. Consequently, expression profiling of microRNA in human cancers correlates with cancer detection, staging, progression, and response to therapies, which boosts the microRNA reverse transcription market.

• Increasing Increase in the Early Diagnosis Rate

With the increase in the successful diagnosis of chronic disease including cancer, anemia, type two diabetes, and others, improved health care professionals and regular training sessions for the professionals for conducting tests accounted for the improvement of diagnosis rate across the globe. Healthcare IT also has the potential, and they are putting in efforts that enhance the rate of diagnosis seeking, and they can also reduce the diagnostics errors. It also helps in detecting the risks associated with the diagnostic process and helps determine the range of the problem. Healthcare IT vendors also share and conduct to share the user experiences. This will help evaluate the consequences of the diagnostic errors, which is helping in improving the rate of diagnosis across various regions of the world. several associations and organizations are taking initiatives to spread awareness about new advanced microRNA sequencing products and technology.

Opportunities

• Rise in Government Funding for Healthcare

Including government, federations, and major market players create opportunities across developing countries. These initiatives by the players and government are helping the users reach out for taking advantage of the policies made for low-income and developing nations and making them aware of the diseases that are preventable if diagnosed earlier.

Restraints/Challenges

However, modern technology microRNA reverse transcription devices lead to the high cost of treatment. The kits require a huge cost for the development process. As the materials need to be sourced and require raw material, they should meet different regulations and others that add up the products' cost. Additionally, the process is time-consuming as it needs sufficient time to fully mature before bringing in the market for use.

Furthermore, any changes that must be re-verified will impact time. The growing developments demanded an effective investment for successful operations and a project risk management plan. The establishment of R&D for conducting research entails high cost, which leads to expensive point of care devices.  Thus, this factor is acting as a major restrain for the market.

Global microRNA reverse transcription market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on microRNA reverse transcription market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

MicroRNA are small endogenous RNA that regulates gene expression post-transcriptionally. MicroRNA are abundantly found in the mammalian types and target approximately 60% of the genes of humans and other mammals. MicroRNA reverse transcription is a crucial regulator of gene expression and a promising candidate for biomarker development.

A single microRNA can target hundreds of mRNAs and influence the expression of many genes. Further, microRNA reverse transcription involved in many allergies’ diseases including eosinophilic esophagitis, asthma and many others which is expected to increase the demand for microRNA reverse transcription. Current methodologies used for microRNA reverse transcription such as RNA-sequencing, microarrays and quantitative PCR are expected to boost the market growth.

Global microRNA reverse transcription market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Post COVID-19 Impact on Global microRNA Reverse Transcription Market

The COVID-19 has negatively affected the healthcare market and also, covid-19 pandemic is expected to leave a long lasting impact in the global microRNA reverse transcription market. The outbreak of the virus forced the general citizens to deal with the virus and its management. This virus has greatly affected the economic sector. The healthcare industry is set to experience a few structural changes in 2022 due to the increasing prevalence of infectious diseases.

Increase in geriatric population and diseases have driven the overall growth of global microRNA reverse transcription market. However, increase in cost in diagnostic devices is expected to hinder the market growth.

Recent Development

• In September 2021, Bio-Rad Laboratories, Inc. announced the partnership with Seegene, Inc., a global leader in multiplex molecular diagnostics, for the clinical development and commercialization of infectious disease molecular diagnostic products. This have increased company’s product portfolio.
• In 2020, Thermo Fisher Scientific Inc., throughout the pandemic, they’ve worked closely with the highest levels of governments and healthcare institutions around the world, as well as with the pharmaceutical and biotech industry to support efforts in research, diagnostic testing, development and production.

Global microRNA Reverse Transcription Market

The global microRNA reverse transcription market based on product type, services, method, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product Type

• Instruments
• Kits and Reagents
• Consumables

On the basis of product type, the global microRNA reverse transcription market is segmented into Instruments, kits and reagents, consumable.

Services

• Sample Collection
• Other Services

On basis of by services, the global microRNA reverse transcription market is segmented into sample collection, other services.

Method

• Reverse Trnscription
• qPCR

On the basis of method, the global microRNA reverse transcription market is segmented into by Reverse Transcription & qPCR.

Application

• Cancer
• Kidney Disease
• Neurological Disease
• Cardiovascular Disease
• Others

On the basis of by application , the global microRNA reverse transcription market is segmented into cancer, kidney disease, neurological disease, cardiovascular disease, others.

End User

• 学术及研究机构
• 生物制药公司
• 合同研究组织
• 诊断中心

根据最终用户，全球 microRNA 逆转录市场细分为学术和研究机构、生物制药公司、合同研究组织、诊断中心。

竞争格局和全球 MicroRNA 逆转录市场份额分析

全球 microRNA 逆转录市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对全球 microRNA 逆转录市场的关注有关。

全球 microRNA 逆转录市场的一些主要参与者包括 Thermofisher Scientific Inc.、Agilent、Illumina, Inc.、Merck KgaA、QIAGEN、Bio-Rad Laboratories, Inc.、MiRXES Pte Ltd.、Abcam plc、Takara Bio Inc.、Quantabio、Horizo​​n Discovery Ltd.、NanoString.、BioGenex、SeqMatic LLC、GenoSensor, LLC、OriGene Technologies, Inc.、System Biosciences, LLC.、HTG Molecular Diagnostics, Inc.、GeneCopoeia, Inc.、New England Biolabs、Miltenyi Biotec 和/或其附属公司、Applied Biological Materials Inc. (abm)、Norgen Biotek Corp.、南京诺唯真生物科技有限公司。 

SKU-67976